DeutschNewstral
Article
thedailyrecord.com on 2019-08-21 18:34
Cerecor has FDA fast track designation for rare disease drug
Related news
FDA grants rare pediatric disease designation to RegenxBio gene therapybizjournals.com- PhaseRx clears hurdle to market with FDA rare disease designationbizjournals.com
- MCelgene's rare disease drug gets FDA approvalmarketwatch.com
- MIovance shares jump on FDA cancer drug fast-track designationmarketwatch.com
Drug for rare form of ALS disease OK’d by FDAocregister.com- FDA approves Alnylam's first-ever drug for rare kidney diseasebizjournals.com
- FDA rejects rare disease drug developed by Cambridge's Akceabizjournals.com
- FDA approves ultra-rare disease drug from Waltham's Sobibizjournals.com
- FDA gives early OK to Alnylam rare disease drugbizjournals.com
FDA Approves Merck’s New Drug For A Rare Lung DiseaseForbes- Leadiant gets FDA approval for treatment for rare diseasethedailyrecord.com
- MCerecor stock soars 17% premarket after FDA grants fast-track designation to treatment for rare disordermarketwatch.com
- Novavax gets FDA fast track designation for flu vaccinethedailyrecord.com
- SA biotech gets FDA orphan drug designationbizjournals.com
- A rare win: North Bay biotech gets FDA approval for drug to treat bone diseasebizjournals.com
Reata stock soars on FDA approval for ultra-rare disease drug after 15 yearsDallas News- MFDA grants a second approval to Ultragenyx drug for rare diseasemarketwatch.com
Rare disease drove two women on a mission to change FDA drug review processCNN
Drug for rare form of Lou Gehrig’s disease OK’d by FDAseattletimes.com- FDA Reverses Decision, Allowing Amicus To File For Rare Disease DrugForbes